Galactosemia in Babies
The short answer
Galactosemia is a rare inherited metabolic disorder where a baby cannot properly process galactose, a sugar found in breast milk and standard formulas. It affects about 1 in 30,000 to 60,000 newborns. Detected through newborn screening, galactosemia requires immediate dietary treatment — switching to a soy-based formula — to prevent serious liver damage, brain injury, and life-threatening illness.
By Age
What to expect by age
Classic galactosemia presents within the first days to weeks of life when a baby begins feeding on breast milk or standard formula. Signs include poor feeding, vomiting, diarrhea, jaundice, lethargy, and failure to gain weight. Without treatment, galactose accumulates and causes liver failure, sepsis (often E. coli), cataracts, and brain damage. Newborn screening catches most cases before serious harm occurs. Treatment involves immediately switching to a soy-based or other galactose-free formula.
Babies on a galactose-restricted diet should be growing and developing well. Monitoring includes checking galactose-1-phosphate levels in the blood. Some babies may still develop cataracts early on despite treatment, so ophthalmologic evaluations are important. If your baby is on treatment and thriving, that is a very positive sign.
As solid foods are introduced, parents must be vigilant about avoiding galactose-containing foods, particularly dairy products. A metabolic dietitian is essential for navigating this transition. Despite good dietary management, some children with classic galactosemia may show speech and language delays or motor difficulties, which are part of the condition and benefit from early intervention services.
Galactosemia requires lifelong dietary restriction of galactose. Even with excellent dietary control, some children may experience learning difficulties, speech delays, or motor challenges. Girls with classic galactosemia may develop premature ovarian insufficiency. Ongoing care with a metabolic team, developmental monitoring, and early intervention services can help optimize outcomes.
What Should You Do?
When to take action
- Your baby's newborn screening was normal for galactosemia
- Your baby tolerates breast milk or standard formula without jaundice, vomiting, or lethargy
- Your baby is gaining weight well and meeting early milestones
- Your treated baby has galactose-1-phosphate levels in the acceptable range
- Your baby's newborn screening showed an abnormal result related to galactosemia — follow up immediately for confirmatory testing
- Your newborn is feeding poorly with persistent vomiting, jaundice, and lethargy that began after starting milk feeds
- Your baby on galactosemia treatment is showing speech or motor delays
- Your newborn is severely jaundiced, not feeding, lethargic, or showing signs of liver failure (bleeding, abdominal swelling) — this is a medical emergency
- Your newborn screening indicates galactosemia and your baby is still receiving breast milk or regular formula — switch to soy formula and contact your medical team immediately
Sources
Related Resources
Related Medical Concerns
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Air Quality and Baby Health
Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.
Altitude Sickness in Babies
Babies and toddlers can experience altitude sickness when traveling above 5,000-8,000 feet (1,500-2,500 meters). Symptoms are harder to recognize in infants because they cannot describe how they feel. Watch for unusual fussiness, poor feeding, disrupted sleep, vomiting, and fast breathing. Gradual ascent is the best prevention. Most pediatricians recommend avoiding sleeping at very high altitudes (above 8,000 feet) with infants when possible, and descending immediately if symptoms appear.
Amblyopia (Lazy Eye) Treatment Timing
Amblyopia (lazy eye) is the most common cause of vision loss in children, affecting 2-3% of the population. It occurs when one eye develops weaker vision because the brain favors the other eye. Early detection and treatment are critical because the visual system is most responsive to treatment during early childhood. Treatment is most effective when started before age 7, though improvement is possible at older ages. Treatment options include patching the stronger eye, atropine eye drops, glasses, or a combination.